PROMIS NEUROSCIENCES INC. (PMN) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
19/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LosePMN / S&P 3.62% / 15.20% |
LosePMN / S&P PMN unavailable / 15.00% |
WinPMN / S&P 153.19% / 50.40% |
| 2026-Q12/3 |
WinPMN / S&P 85.94% / -4.33% |
LosePMN / S&P PMN unavailable / 11.30% |
WinPMN / S&P 1081.08% / 27.70% |
| 2025-Q40/3 |
LosePMN / S&P -36.47% / 2.65% |
LosePMN / S&P PMN unavailable / 9.00% |
LosePMN / S&P -1489.56% / 13.40% |
| 2025-Q31/3 |
LosePMN / S&P -10.42% / 8.12% |
LosePMN / S&P PMN unavailable / 4.61% |
WinPMN / S&P 10170.00% / 13.45% |
| 2025-Q21/3 |
LosePMN / S&P -31.43% / 10.94% |
LosePMN / S&P PMN unavailable / 4.83% |
WinPMN / S&P 1520.00% / 10.63% |
| 2025-Q11/3 |
LosePMN / S&P -26.32% / -4.27% |
LosePMN / S&P PMN unavailable / 4.98% |
WinPMN / S&P 250.00% / 10.57% |
| 2024-Q40/3 |
LosePMN / S&P -24.00% / 2.41% |
LosePMN / S&P PMN unavailable / 5.25% |
LosePMN / S&P -320.35% / 6.15% |
| 2024-Q30/3 |
LosePMN / S&P -16.67% / 5.89% |
LosePMN / S&P PMN unavailable / 5.89% |
LosePMN / S&P -94.87% / 6.11% |
| 2024-Q20/3 |
LosePMN / S&P -21.47% / 4.28% |
LosePMN / S&P PMN unavailable / 5.38% |
LosePMN / S&P -76.83% / 5.12% |
| 2024-Q11/3 |
WinPMN / S&P 66.09% / 10.56% |
LosePMN / S&P PMN unavailable / 5.71% |
LosePMN / S&P -72.59% / 5.59% |
| 2023-Q40/3 |
LosePMN / S&P -41.92% / 11.69% |
LosePMN / S&P PMN unavailable / 6.81% |
LosePMN / S&P -53.11% / 7.78% |
| 2023-Q31/3 |
LosePMN / S&P -48.97% / -3.27% |
LosePMN / S&P PMN unavailable / 7.52% |
WinPMN / S&P 11.43% / -5.03% |
| 2023-Q21/3 |
LosePMN / S&P -17.97% / 8.74% |
LosePMN / S&P PMN unavailable / 9.50% |
WinPMN / S&P 131.25% / -8.57% |
| 2023-Q12/3 |
WinPMN / S&P 8.99% / 7.50% |
LosePMN / S&P PMN unavailable / 10.77% |
WinPMN / S&P 237.50% / -15.69% |
| 2022-Q40/3 |
LosePMN / S&P -29.20% / 7.56% |
LosePMN / S&P PMN unavailable / 11.88% |
LosePMN / S&P PMN unavailable / -17.99% |
| 2022-Q30/3 |
LosePMN / S&P -5.55% / -4.88% |
LosePMN / S&P PMN unavailable / 13.47% |
LosePMN / S&P PMN unavailable / -1.41% |
| 2022-Q21/3 |
WinPMN / S&P 8.17% / -16.10% |
LosePMN / S&P PMN unavailable / 13.71% |
LosePMN / S&P PMN unavailable / 11.04% |
| 2022-Q10/3 |
LosePMN / S&P -9.09% / -4.60% |
LosePMN / S&P PMN unavailable / 15.97% |
LosePMN / S&P PMN unavailable / 42.23% |
| 2021-Q40/3 |
LosePMN / S&P -21.43% / 11.03% |
LosePMN / S&P PMN unavailable / 15.00% |
LosePMN / S&P PMN unavailable / 96.40% |
| 2021-Q30/3 |
LosePMN / S&P -17.65% / 0.58% |
LosePMN / S&P PMN unavailable / 10.77% |
LosePMN / S&P PMN unavailable / 69.42% |
| 2021-Q20/3 |
LosePMN / S&P 0.00% / 8.55% |
LosePMN / S&P PMN unavailable / 6.58% |
LosePMN / S&P PMN unavailable / 51.81% |
| 2021-Q11/3 |
WinPMN / S&P 112.50% / 6.17% |
LosePMN / S&P PMN unavailable / -1.06% |
LosePMN / S&P PMN unavailable / 7.39% |
| 2020-Q40/3 |
LosePMN / S&P -27.27% / 12.15% |
LosePMN / S&P PMN unavailable / -3.72% |
LosePMN / S&P PMN unavailable / -33.42% |
| 2020-Q30/3 |
LosePMN / S&P -31.25% / 8.93% |
LosePMN / S&P PMN unavailable / -2.04% |
LosePMN / S&P PMN unavailable / -27.10% |
| 2020-Q21/3 |
WinPMN / S&P 77.78% / 20.54% |
LosePMN / S&P PMN unavailable / -0.46% |
LosePMN / S&P PMN unavailable / -27.11% |
| 2020-Q10/3 |
LosePMN / S&P -30.77% / -19.60% |
LosePMN / S&P PMN unavailable / 3.47% |
LosePMN / S&P PMN unavailable / -14.75% |
| 2019-Q40/3 |
LosePMN / S&P -27.78% / 9.07% |
LosePMN / S&P PMN unavailable / 5.36% |
LosePMN / S&P PMN unavailable / 2.99% |
| 2019-Q30/3 |
LosePMN / S&P -5.26% / 1.70% |
LosePMN / S&P PMN unavailable / 5.02% |
LosePMN / S&P PMN unavailable / 0.21% |
| 2019-Q20/3 |
LosePMN / S&P -17.39% / 4.30% |
LosePMN / S&P PMN unavailable / 6.64% |
LosePMN / S&P PMN unavailable / 8.65% |
| 2019-Q11/3 |
WinPMN / S&P 15.00% / 13.65% |
LosePMN / S&P PMN unavailable / 8.12% |
LosePMN / S&P PMN unavailable / 14.29% |
| 2018-Q40/3 |
LosePMN / S&P -16.67% / -13.52% |
LosePMN / S&P PMN unavailable / 9.05% |
LosePMN / S&P PMN unavailable / 18.23% |
| 2018-Q30/3 |
LosePMN / S&P -20.00% / 7.71% |
LosePMN / S&P PMN unavailable / 10.21% |
LosePMN / S&P PMN unavailable / 19.06% |
| 2018-Q20/3 |
LosePMN / S&P -16.67% / 3.43% |
LosePMN / S&P PMN unavailable / 9.03% |
LosePMN / S&P PMN unavailable / 14.46% |
| 2018-Q11/3 |
WinPMN / S&P 111.76% / -0.76% |
LosePMN / S&P PMN unavailable / 7.68% |
LosePMN / S&P PMN unavailable / 12.46% |
| 2017-Q40/3 |
LosePMN / S&P -15.00% / 6.64% |
LosePMN / S&P PMN unavailable / 7.03% |
LosePMN / S&P PMN unavailable / 13.82% |
| 2017-Q30/3 |
LosePMN / S&P -4.76% / 4.48% |
LosePMN / S&P PMN unavailable / 5.68% |
LosePMN / S&P PMN unavailable / 17.57% |
| 2017-Q21/3 |
WinPMN / S&P 90.91% / 3.09% |
LosePMN / S&P PMN unavailable / 4.83% |
LosePMN / S&P PMN unavailable / 17.74% |
| 2017-Q11/3 |
WinPMN / S&P 10.00% / 6.07% |
LosePMN / S&P PMN unavailable / 3.67% |
LosePMN / S&P PMN unavailable / 13.32% |
| 2016-Q41/3 |
WinPMN / S&P 25.00% / 3.82% |
LosePMN / S&P PMN unavailable / 2.09% |
LosePMN / S&P PMN unavailable / 7.05% |
| 2016-Q30/3 |
LosePMN / S&P -33.33% / 3.85% |
LosePMN / S&P PMN unavailable / 0.20% |
LosePMN / S&P PMN unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | PMN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 3.63% | 20.78% |
| Annualized return | 3.63% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | PMN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -94.17% | 83.14% |
| Annualized return | -43.36% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | PMN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -90.67% | 319.30% |
| Annualized return | -21.12% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |